Products Affected - Description
Reason for the Shortage
Perrigo acquired Neptazane tablets and methazolamide tablets from Fera.
Methazolamide Tablets, Perrigo
25 mg tablets, 100 count (NDC 00574-0790-01)
50 mg tablets, 100 count (NDC 00574-0791-01)
Neptazane Tablets, Perrigo
25 mg tablets, 90 count (NDC 00574-0786-90)
50 mg tablets, 90 count (NDC 00574-0787-90)
Methazolamide Tablets, Sandoz
25 mg tablets, 100 count (NDC 00781-1072-01)
50 mg tablets, 100 count (NDC 00781-1071-01)
Estimated Resupply Dates
All presentations are available.
February 23 and January 28, 2015; October 17, September 18, June 5, March 20 and 31, and February 12, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins